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an average of 5.1 times, underwent 35 cycles of either
intracytoplasmic sperm injection (ICSI) or standard in-vitro
fertilization (IVF). Embryo transfer on days 2-3 of develop-
ment was performed in all cycles and supernumerary embryos
were further cultured in a cell-free culture system. Whenever
blastocysts were developed, they were transferred at a second
transfer 2-3 days following the first transfer.
Results: A total of 202 transferable embryos were obtained,
of which 81 were transferred on days 2-3 of embryonic
development in all treatment cycles (mean of 2.3 embryos per
transfer). A total of 121 embryos were further cultured of
which 36 embryos (27.9%) reached the stages of early,
expanded or hatching blastocysts on days 5-7. In 19 cycles
(group A), 24 blastocysts were transferred 2-3 days following
the first transfer (mean of 1.3 blastocysts per transfer). In 16
cycles (group B), no blastocysts were available for transfer
andthus a second transfer was not performed. Higher pregnancy
and implantation rates were obtained in group A (42%
and 20.3%) as compared to group B (25% and 11.1%)
respectively.
Conclusion: Our results demonstrate the beneficial effect of
a double embryo transfer in cases of repeated implantation
failure. The observation that a relatively high pregnancy rate
was obtained in cases of a failure to achieve blastocyst
development indicates that in-vitro selection for embryonic
development may not always reflect in-vivo selection criteria.
Performing a double embryo transfer of both cleavage stage
as well as blastocysts provides the advantages of both environ-
ments for the selection of embryos possessing the potential
for a complete embryonic development.
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Introduction: There is a need for the clinician to provide his
patients with the most efficient treatment, in terms of take
home baby rate, cost per initiated cycle and respect for ethical
and legal issues. In Switzerland, the selection at the embryo
stage is no longer allowed, necessitating freezing at the zygote
stage. The maximum number of embryos transferred is legally
limited to three. Moreover, to decrease the number of multiple
pregnancies, only two embryos are generally transferred when
the patients are <35 years old. Consequently, more zygotes
arecryopreserved per oocyte retrieval, and more transfer cycles
are needed to replace these cryopreserved zygotes, with an
increase of the overall cost of the treatment. The aim of this
retrospective study was to compare luteinizing hormone (LH)
urinary test, a low cost ovulation monitoring method, with the
standard approach measuring plasma LH, progesterone and
oestradiol levels, for the transfer of cryopreserved zygotes in
natural cycles.
Materials and methods: Zygotes were frozen with the slow
protocol using 1.5 M propanediol and 0.1 M sucrose in human
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tubal fluid medium containing SSR-2 (Medicult) and 0.5%
human serum albumin. Zygotes were thawed 24-26 h before
transfer. The embryo transfer was performed 3 days after the
LH surge monitored using two different methods: a twice daily
urinary test performed in the morning (INTEX-Ovulationstest;
INTEX Pharmazeutische Produkte AG, Muttenz, Switzerland),
or a plasma determination of LH, progesterone and oestradiol.
All the patients using the urinary test received a short oral
instruction and were asked to call the Unit on the day of the
LH surge. In the event of a problem (difficulties in interpreting
the LH urinary tests, ovulation delay, etc.), they were invited
to come to the Unit for complementary blood testing. A
plasma pregnancy test (human chorionic gonadotrophin) was
performed 14 days after embryo transfer and clinical pregnancy
was diagnosed 28 or 35 days after embryo transfer using an
ultrasound examination (cardiac activity observation).
Results: From January 1996 to December 1998, 314 spon-
taneously ovulating patients (21-45 years old) underwent 544
thawed embryo transfers using natural cycles. Blood test
monitoring was used for 390 cycles (group A, 220 patients),
whereas urinary testing was used for 121 cycles (group B, 81
patients). For 33 cycles, the urinary testing was problematic
and blood testing was used to confirm or determine the
ovulation (group C, 31 patients). The mean number of blood
tests was 3 for group A and 1.5 for group C. The mean age
of the patients, the mean number of transferred embryos and
the mean embryo score were the same in the three groups.
The percentage of eggs originating from intracytoplasmic
sperm injection cycles (,...,50%) was similar for the three groups.
The pregnancy rate per embryo transfer was 16% for group
A, 18% for group Band 27% for group C (not significant)
with an implantation rate of 9.3%, 9.8% and 19.7% (P <
0.03) respectively. The mean cost for a cycle in group B was
around 40% lower than in group A (740 versus 1200 FRS),
for a similar rate of success. The cost in group C was
intermediate.
Conclusion: These data clearly show that most of the spon-
taneously ovulating patients can monitor their LH surge at home
using a low cost urinary test after adequate oral instruction. In
the event of a problem, blood testing can still be performed,
and, in almost every case, the ovulation can be confirmed or
determined and the embryo transferred. The use of a urinary
test is efficient in terms of pregnancy and implantation rates
and cost-effective, as an important economy can be achieved
for each thawed transfer cycle. Following this retrospective
analysis, the actual policy of the Unit is to propose the
urinary test to all the patients presenting suitable ovulation
characterized during the pre-in-vitro fertilization control cycle.
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Introduction: In-vitro fertilization (IVF) attempts are fre-
quently unsuccessful because embryos placed into the uterus
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